SEC FORM 4
$148,467.59
Replimune Group, Inc. (REPL)
Sale of 11,447 shares at $12.97 per share.
Reporting Person Xynos Konstantinos · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001104659-26-095006 · filed 2026-08-12 · View filing →